Additionally, significant predictors for DFS in patients with an adenocarcinoma component were STMN1 and GRP78/BiP levels, and significant predictors for DFS in patients with a non-adenocarcinoma component were disease stage and VEGFR2 level (Table 3). Here, STMN1 is linked to adenocarcinoma.